`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`PAR PHARMACEUTICAL, INC.,
`
`and
`
`LUPIN LTD. and LUPIN PHARMACEUTICALS, INC.
`Petitioners,
`
`v.
`
`HORIZON THERAPEUTICS, INC.,
`Patent Owner.
`____________
`
`Case IPR2015-011171
`Patent 8,642,012 B2
`____________
`
`
`PARTIES’ JOINT OBJECTIONS TO DEMONSTRATIVE EXHIBITS
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`1 Case IPR2016-00283, instituted on a petition filed by Lupin Ltd. and Lupin
`
`Pharmaceuticals, Inc., has been joined with this proceeding.
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.70 and Paper No. 48, the parties submit the
`
`IPR2015-01117
`Patent 8,642,012
`
`
`
`
`following remaining objections:
`
`1.
`
`Petitioners object to Patent Owner’s slides 15 and 16 because they cite
`
`portions of Ex. 1016 (slide 15 only) and Ex. 2027 (slides 15 and 16) that are not
`
`included in Patent Owner’s Corrected Response to Petition (Paper No. 41, “PO
`
`Response”), and include new evidence (Ex. 2029, “Hawk”) that is not included in
`
`the PO Response. See also Paper 47, n.2; July 12, 2016 email from Aziz Burgy to
`
`Trials@uspto.gov.
`
`2.
`
`Petitioners object to Patent Owner’s slide 18 because it includes
`
`details regarding Sherwin’s experiments in humans, purportedly from pages 670-
`
`73 of Ex. 2027, which details and pages were not presented in PO’s Response.
`
`3.
`
`Patent Owner objects to Petitioners’ July 19, 2016 demonstratives,
`
`which were served after the parties had exchanged final demonstratives on July 15,
`
`2016, as required by 37 C.F.R. § 42.70(b), because, without prior notice to the
`
`Patent Owner, Petitioners substantively altered virtually every slide from its
`
`originally-served version as follows: Slides 7-8, 51 and 82 include substantive
`
`changes to the text of the slides; and 92 out of 104 of Petitioners slides were
`
`amended to add new citations to the record.
`
`
`
`
`
`
`
`1
`
`
`
`
`Date: July 22, 2016
`
`
`
`
`
`
`
`IPR2015-01117
`Patent 8,642,012
`
`Respectfully Submitted,
`
`___________________________
`David H. Silverstein (Reg. No. 61,948)
`Aziz Burgy (Reg. No. 51,514)
`Axinn, Veltrop & Harkrider LLP
`950 F Street, N.W.
`Washington, DC 20004
`Tel: (202) 912-4700
`Attorneys for Petitioner
`Par Pharmaceutical, Inc.
`
`Elizabeth J. Holland (Reg. No. 47,657)
`Cynthia Lambert Hardman (Reg. No. 53,179)
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 459-7230
`Attorneys for Petitioners
`Lupin Ltd. and Lupin Pharmaceuticals, Inc.
`
`
`Robert Green (Reg. No. 27,555)
`GREEN GRIFFITH & BORG-BREEN LLP
`NBC Tower, Suite 3100
`455 North Cityfront Plaza Drive
`Chicago, Illinois 60611
`(312) 883-8000
`Lead Counsel for Patent Owner
`Horizon Therapeutics, Inc.
`
`Matthew C. Phillips (Reg. No. 43,403)
`Backup Counsel for Patent Owner
`Horizon Therapeutics, Inc.
`
`2
`
`
`
`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e), 42.105(a))
`
`IPR2015-01117
`Patent 8,642,012
`Certificate of Service
`
`
`The undersigned hereby certifies that the above-captioned “Parties’ Joint
`
`Objections to Demonstrative Exhibits” was served in its entirety on July 22, 2016
`
`through the Patent Trial and Appeal Board End to End system, and additionally
`
`upon the following parties via Electronic Mail:
`
`For Patent Owner:
`
`For Petitioner Lupin:
`
`Lauren Stevens:
`lstevens@horizonpharma.com
`Matthew C. Phillips:
`matthew.phillips@renaissanceiplaw.com
`Dennis Bennett:
`dennisbennett@globalpatentgroup.com
`
`Robert Green:
`rgreen@greengriffith.com
`Emer Simic: esimic@greengriffith.com
`Jessica Tyrus: jtyrus@greengriffith.com
`
`
`Date: July 22, 2016
`Axinn, Veltrop & Harkrider LLP
`950 F Street, N.W.
`Washington, DC 20004
`Tel: (202) 912-4700
`
`
`
`
`
`
`
`Elizabeth J. Holland
`Cynthia Lambert Hardman
`GOODWIN PROCTER LLP
`eholland@goodwinproctor.com
`chardman@goodwinprocter.com
`
`Respectfully Submitted,
`
`
`David H. Silverstein
`Registration No. 61,948
`Attorney for Petitioner
`Par Pharmaceutical, Inc.
`
`1
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
